AMO's Healon viscoelastic and Hoya's iSpheric IOL
Please click on any of the headlines below to see the full story.
AMO viscoelastic gets FDA OK
AMO's Healon D latex-free viscoelastic has been granted premarket approval by the FDA. The clear dispersive ophthalmic viscosurgical device (OVD) is designed to be used during phacoemulsification, intraocular lens (IOL) implantation, keratoplasty and glaucoma filtration surgery.
iSpheric IOL makes US debut
The iSpheric Model YA-60BB intraocular lens (IOL) (Hoya) has received FDA market approval. The lens has been available in Europe since 2003.
For up-to-date news and announcements, please check the latest news section of our website. Alternatively, please sign up for our weekly newsletter.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.